SCHEMBL20710059

SCHEMBL20710059

Cc1nc(C(F)(F)F)cn1CC(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KB1 P23443 3/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ DGAT1 O75907 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ PTGS2 P35354 5/20 0.32
▸ PTGS1 P23219 2/20 0.32
▸ STIM1 Q13586 1/20 0.32
▸ ORAI1 Q96D31 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ CRHBP P24387 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ CRHR2 Q13324 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ HSP90AB1 P08238 1/20 0.31
▸ PRKACA P17612 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22143470 0.81 ALDH1A1 (0.46) DGAT1PTGS2PTGS1STIM1ORAI1
SCHEMBL25516552 0.76 DGAT1 (0.36) DGAT1PTGS2PTGS1STIM1ORAI1
SCHEMBL20710061 0.76 DGAT1 (0.36) DGAT1PTGS2PTGS1STIM1ORAI1
SCHEMBL13274541 0.75 RPS6KB1 (0.50) RPS6KB1GSK3BTLR7POLBALDH1A1
SCHEMBL31625051 0.74 DGAT1 (0.39) DGAT1PTGS2PTGS1
SCHEMBL31537627 0.74 DGAT1 (0.39) DGAT1ACHEPTGS2PTGS1
SCHEMBL15484840 0.72 KDM4E (0.44) POLBPTGS2PTGS1ALDH1A1TSHR
SCHEMBL23234037 0.72 PTGS2 (0.34) PTGS2PTGS1STIM1ORAI1CYP3A4
SCHEMBL25463476 0.69 CYP3A4 (0.35) DGAT1CYP3A4CYP2D6TSHRCRHBP
SCHEMBL17198879 0.69 HTT (0.38) DGAT1PTGS2PTGS1STIM1ORAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028078-B2 Itraconazole analogs and use thereof THE JOHNS HOPKINS UNIVERSITY (US) 2021-06-08 — — US disclosed
US-20190040046-A1 ITRACONAZOLE ANALOGS AND USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-02-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190040046-A1 ITRACONAZOLE ANALOGS AND USE THEREOF SHH, GLI1, KDR RPS6KB1 1184/4885GSK3B 704/4885DGAT1 1769/4885
US-11028078-B2 Itraconazole analogs and use thereof SHH, GLI1, KDR RPS6KB1 1184/4885GSK3B 704/4885DGAT1 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback